|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Fenofibrate]] |
| {{Fenofibrate}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Adverse Reactions==
| |
| | |
| ===Clinical Trials Experience===
| |
| | |
| Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect rates observed in clinical practice.
| |
| | |
| Adverse events reported by 2% or more of patients treated with fenofibrate and greater than placebo during double-blind, placebo-controlled trials, regardless of causality, are listed in Table 1. Adverse reactions led to discontinuation of treatment in 5.0% of patients treated with fenofibrate and in 3.0% treated with placebo. Increases in liver function tests were the most frequent events, causing discontinuation of fenofibrate treatment in 1.6% of patients in double-blind trials.
| |
| | |
| {|
| |
| |[[File:Fenofibrate01.jpg|thumb|800px]]
| |
| |}
| |
| | |
| | |
| ===Postmarketing Experience===
| |
| | |
| The following adverse reactions have been identified during post approval use of fenofibrate:[[ myalgia]], [[rhabdomyolysis]], [[pancreatitis]], [[renal failure]], [[muscle spasms]],[[ acute renal failure], [[hepatitis]], [[cirrhosis]], [[anemia]], [[arthralgia]], [[asthenia]] and severely depressed HDL-cholesterol levels. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a casual relationship to drug exposure.<ref>{{Cite web | last = | first = | title = ANTARA (FENOFIBRATE) CAPSULE [LUPIN PHARMA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ebf783-64df-4ffa-9e84-f8fdf4d245d4 | publisher = | date = | accessdate = 12 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| {{Lipid modifying agents}}
| |
| {{Antigout preparations}}
| |
| | |
| [[Category:Fibrates]]
| |
| [[Category:Prodrugs]]
| |
| [[Category:Organochlorides]]
| |
| [[Category:Benzophenones]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Carboxylate esters]]
| |